Abstract:Reactive oxygen species (ROS) play a critical role in the pathogenesis of osteoarthritis. The injection of a single antioxidant drug is characterized by low drug utilization and short residence time in the articular cavity, limiting the therapeutic effect of antioxidant drugs on osteoarthritis. Currently, the drug circu-lation half-life can be extended using delivery vehicles such as liposomes and microspheres, which are widely used to treat diseases. In addition, the composite carriers of liposomes and hydrogel microspheres can combine the advantages of different material forms and show stronger plasticity and flexibility than traditional single carriers, which are expected to become new local drug delivery systems. Chondroitin sulfate, a sulfated glycosaminoglycan commonly found in native cartilage, has good antioxidant properties and degradability and is used to develop an injectable chondroitin sulfate hydrogel by covalent modifi-cation with photo-cross-linkable methacryloyl groups (ChsMA). Herein, ChsMA microgels anchored with liquiritin (LQ)-loaded liposomes (ChsMA@Lipo) were developed to delay the progression of osteoarthri-tis by dual antioxidation. On the one hand, the antioxidant drug LQ wrapped in ChsMA@Lipo microgels exhibits significant sustained-release kinetics due to the double obstruction of the lipid membrane and the hydrogel matrix network. On the other hand, ChsMA can eliminate ROS through degradation into chondroitin sulfate monomers by enzymes in vivo . Therefore, ChsMA@Lipo, as a degradable and dual an-tioxidant drug delivery platform, is a promising option for osteoarthritis treatment.Statement of significanceCompared with the traditional single carrier, the composite carriers of hydrogel microspheres and lipo-some can complement the advantages of different materials, which shows stronger plasticity and flexibil-ity, and is expected to become a new and efficient drug delivery system. ChsMA@Lipo not only attenuates IL-1 beta-induced ECM degradation in chondrocytes but also inhibits the M1 macrophages polarization and the inflammasome activation. The obtained ChsMA@Lipo alleviates the progression of osteoarthritis in vivo , which is promising for osteoarthritis treatment.(c) 2022 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Nanocrystal-chitosan particles for intra-articular delivery of disease-modifying osteoarthritis drugs

Intra-articular Injection of PLGA/polydopamine Core-Shell Nanoparticle Attenuates Osteoarthritis Progression

Intra-articular Nanodrug Delivery Strategies for Treating Osteoarthritis.

Chondrocyte Membrane–coated Nanoparticles Promote Drug Retention and Halt Cartilage Damage in Rat and Canine Osteoarthritis

Chondroitin Sulfate Microspheres Anchored with Drug-Loaded Liposomes Play a Dual Antioxidant Role in the Treatment of Osteoarthritis

Nanoarchitectonics of Injectable Biomimetic Conjugates for Cartilage Protection and Therapy Based on Degenerative Osteoarthritis Progression

A combination of chitosan nanoparticles loaded with celecoxib and kartogenin has anti-inflammatory and chondroprotective effects: Results from an in vitro model of osteoarthritis

Intra-articular Injection of Kartogenin-Conjugated Polyurethane Nanoparticles Attenuates the Progression of Osteoarthritis

Magnetically Guided Intracartilaginous Delivery of Kartogenin Improves Stem Cell-Targeted Degenerative Arthritis Therapy.

Nanoparticle–Cartilage Interaction: Pathology-Based Intra-articular Drug Delivery for Osteoarthritis Therapy

Spray-dried nanocrystal-loaded polymer microparticles for long-term release local therapies: an opportunity for poorly soluble drugs

Promoting chondrogenesis by targeted delivery to the degenerating cartilage in early treatment of osteoarthritis

Intra-articular Injection of Chitosan-Based Supramolecular Hydrogel for Osteoarthritis Treatment

Development of Targeted Nanoscale Drug Delivery System for Osteoarthritic Cartilage Tissue

Construction of a Highly Targeted Therapeutic Nanoparticle for Osteoarthritis

Cartilage-targeted drug nanocarriers for osteoarthritis therapy

Characterization of Calcium- and Strontium-Polyphosphate Particles Toward Drug Delivery into Articular Cartilage

Intra-articular delivery of antioxidative polymer-based nanospheres reduces intracellular reactive oxygen species in macrophages and alleviates cartilage damage in a rat model

Injectable Regenerated Silk Fibroin Micro/Nanosphere with Enhanced Permeability and Stability for Osteoarthritis Therapy

Multifunctional polymeric nanocapsules with enhanced cartilage penetration and retention for osteoarthritis treatment